|
1
|
Screening for epidermal growth factor receptor mutations in lung cancer.
|
N Engl J Med
|
2009
|
13.47
|
|
2
|
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.
|
PLoS One
|
2009
|
1.36
|
|
3
|
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.
|
J Clin Oncol
|
2005
|
1.14
|
|
4
|
Applications of genomics in NSCLC.
|
Lung Cancer
|
2005
|
0.90
|
|
5
|
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.
|
Oncol Rep
|
2007
|
0.86
|
|
6
|
Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma.
|
Clin Transl Oncol
|
2014
|
0.82
|